kb 5492 has been researched along with hydrogen in 1 studies
Studies (kb 5492) | Trials (kb 5492) | Recent Studies (post-2010) (kb 5492) | Studies (hydrogen) | Trials (hydrogen) | Recent Studies (post-2010) (hydrogen) |
---|---|---|---|---|---|
8 | 0 | 0 | 28,781 | 399 | 11,492 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, H; Morimoto, Y; Oshima, S; Shimohara, K; Sukamoto, T | 1 |
1 other study(ies) available for kb 5492 and hydrogen
Article | Year |
---|---|
Effects of KB-5492, a new anti-ulcer agent with a selective affinity for the sigma-receptor, on aspirin-induced disruption of the rat gastric mucosal barrier.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Ulcer Agents; Aspirin; Diterpenes; Gastric Mucosa; Hydrogen; Male; Membrane Potentials; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sodium | 1994 |